Cross-fund · 5 holders
BCRX
BIOCRYST PHARMACEUTICALS INC
CUSIP 09058V103
5
Tracked holders
$410.0M
Aggregate value
47,095,084
Shares
6
Active funds
Funds holding BCRX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $215.6M | — | +1,513,197 | +7.2% |
| Vanguard | Institutional | Q4 2025 | $173.7M | — | +482,494 | +2.2% |
| Citadel | Multi-Strategy | Q1 2026 | $11.6M | — | -297,256 | -19.7% |
| BridgewaterFEAT | Macro | Q1 2026 | $6.1M | 0.03% | +402,482 | +170.9% |
| Millennium | Multi-Strategy | Q1 2026 | $3.0M | — | +180,095 | +130.9% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -1,213,576 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.